Table 5.
The significantly enriched analysis of predicted target genes.
| Term | Description | Count | p-value |
|---|---|---|---|
| MF_GO:0005515 | protein binding | 106 | 0.010477 |
| CC_GO:0005634 | nucleus | 73 | 0.001961 |
| BP_GO:0006351 | transcription, DNA-templated | 30 | 0.019201 |
| MF_GO:0003677 | DNA binding | 26 | 0.033161 |
| BP_ GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 24 | 1.21E-04 |
| BP_GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 18 | 9.06E-04 |
| MF_GO:0003700 | transcription factor activity, sequence-specific DNA binding | 17 | 0.036439 |
| MF_GO:0043565 | sequence-specific DNA binding | 13 | 0.006885 |
| BP_GO:0030198 | extracellular matrix organization | 12 | 4.54E-06 |
| BP_GO:0001525 | angiogenesis | 12 | 1.54E-05 |
| CC_GO:0005578 | proteinaceous extracellular matrix | 12 | 7.45E-05 |
| BP_GO:0006366 | transcription from RNA polymerase II promoter | 12 | 0.014271 |
| CC_GO:0048471 | perinuclear region of cytoplasm | 12 | 0.04456 |
| BP_GO:0030574 | collagen catabolic process | 10 | 1.39E-08 |
| CC_GO:0005788 | endoplasmic reticulum lumen | 10 | 1.26E-04 |
| MF_GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 10 | 0.010699 |
| BP_GO:0008283 | cell proliferation | 10 | 0.01151 |
| BP_GO:0043066 | negative regulation of apoptotic process | 10 | 0.039644 |